An interventional study of nutritional support in Malnutrition, sponsored by Peking Union Medical College. Not yet recruiting at 2 sites in China. Open to participants aged 18 Years to 90 Years. Per ClinicalTrials.gov, last updated 2026-01-09.
Sponsored by Peking Union Medical College · Not applicable, Interventional, and Supportive care
Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →
Among 59 studies in Malnutrition with a site in China — 20 open to participants now, 21 under way, 1 of them phase 3. Malnutrition · China.
Among the 59 studies in Malnutrition with a site in China, this one is the 5th largest by planned enrollment of the 32 interventional ones that give a count, is one of 4 that started in 2026, is one of 19 with no phase, reaches primary completion later than 19 of the 20 other live ones, and was the 41st registered.
1,278 studies on the registry are indexed under Malnutrition; 231 are open to participants now.
Browse Malnutrition studies →20 of the 59 studies in Malnutrition with a site in China are open now. Recruiting first, the newest first:
Huashan Hospital · Sites in China
Ages 61+
The Second Hospital of Nanjing Medical University · Sites in China
Ages 18–100
The Second Hospital of Nanjing Medical University · Sites in China
Ages 18+
Xiaoqin Luo · Sites in China
Ages 18+
Chengdu Qingshan Likang Pharmaceutical Co., Ltd · Sites in China
Ages 18–75
A study can be open while its sites in China have not opened yet or have stopped. Only those recruiting at a site in China →
Of the 150 Malnutrition studies recruiting now, 84 (56%) set no upper age limit and 44 (29%) stop at 75 or younger; 40 take children under 18; 30 take healthy volunteers.
This study: 18 Years to 90 Years · all sexes · no healthy volunteers.
The full table on the hub →This tab as a report to print or save as PDF → With an account.
59 studies; the count open now beside each. This study's row is marked.
First in 1989; this study’s year is marked. 4 started in 2026.
By drug class, each counting the studies that test any of its medicines:
This study's planned enrollment of 400 is above the median of 119 across 844 interventional studies indexed under Malnutrition.
Median enrollment 120 across the 32 interventional studies, 500 across the 27 observational. Of the 24 that completed or were terminated, 1 (4%) have results posted.
This tab as a report to print or save as PDF → With an account.
3 of 59 have an industry lead sponsor. The 10 most frequent:
Peking Union Medical College is the lead sponsor of 58 studies on the registry; 17 are open to participants now.
Peking Union Medical College has 2 studies filed under Malnutrition — fewer than ten, so there is no comparison to draw.
5 of the studies in Malnutrition with a site in China that are under way reach primary completion within a year, 0 of them phase 3. Phase 3 first, then by date:
| Study | Primary completion |
|---|---|
| NCT05242055Capital Medical UniversityIntegrated Diagnosis and Treatment of CKD on Outcomes | 2026-12-31 |
| NCT06837194The Second Hospital of Nanjing Medical UniversityWashed Microbiota Transplantation Combined with Enteral Nutrition for Gastroptosis | 2027-02-01 |
| NCT07136727The First Affiliated Hospital of Xinxiang Medical CollegeAI-Assisted Comprehensive Management for Cancer Patients With Comorbidities (GCOG-CG001) | 2027-05-01 |
| NCT07565415Nanfang Hospital, Southern Medical UniversityNanocrystalline Megestrol Acetate Versus Placebo for Anorexia in Patients With Unresectable Hepatocellular Carcinoma Receiving TACE Combined With Targeted and Immunotherapy | 2027-09-01 |
| NCT07850375Institute of Hematology & Blood Diseases Hospital, ChinaNutritional Intervention for Patients Undergoing Allogeneic Hematopoietic Stem Cell Transplantation | 2027-10-30 |
Add all 5 to your calendar (.ics) → With an account.
Among the 59 studies in Malnutrition with a site in China, from their registry updates:
This tab as a report to print or save as PDF → With an account.
The impact of nutritional support for the patients at nutritional risk on clinical outcomes and cost-effectiveness.
Although it was often to hear that malnutrition ratio in Aisa hospitalized patient was 40%-70% , there was no evidence to elaborate the prevalence of nutritional risk and malnutrition on hospitalized patients of Asia. Also in USA no data for nutritional risk. In 2002, scientists group headed by Kondrup from : European Society for Parenteral and Enteral Nutrition demonstrated that randomized controlled clinical trials showed patients may get benefit from nutrition support when they with nutrition risk. Based on these evidences, a simpler method was established by European Society for Parenteral and Enteral Nutrition in year 2002 in Munich \& it was demonstrated useful to evaluate the appropriate use of nutrition support at present time. This method was named as Nutrition Risk Screening (NRS).
Investigators propose to survey the prevalence of malnutrition \& nutrition risk in large cities' large/middle size hospitalized patients in China, Europe and USA use NRS tool. As well, we also aim to figure out the current nutrition support status in current large/middle size hospitals through this survey.
Investigators also propose to evaluate the cost-effectiveness of parenteral nutrition, enteral nutrition and non-nutritional support, and to examine the clinical outcomes of nutritional support in certain patients at nutritional risk identified by NRS-2002.
For international cooperation, the partners are Professor Kondrup of Europe and Professor Nolan from Johns Hopkins Hospital,there are students from a cooperative project with Johns Hopkins Hospital for Doctor of Philosophy students 2005-2011.
Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.
Exclusion Criteria:
All participants in this group will receive proper nutritional support.
Dietary Supplement: nutritional support
All participants in this group will receive routine hospital management, without additional nutritional interventions.
nutritional support
The incidence of Infectious complication
A infectious complication was defined as as the presence of recognized pathogens in body tissues that normally are sterile, confirmed by the results of culture and supported by clinical, radiologic or hematologic evidence of infection
Time frame: during the hospital stay
Total cost amount
The total cost amount was considered to contain 3 items in our study. The first item was the cost of nutrition support, including nutrition solutions, nursing, physician, and other staff supervision of nutrition support preparation, administration, and catheter placement and maintenance. The second item was the cost of the infectious complication.The third item was 'other costs' associated with the hospital admission, calculated from the total costs from which the cost of nutrition support and infectious complications were subtracted.
Time frame: during the hospital stay
Start is estimated for Dec 2026; primary completion for Jan 2040, 157 months later.
Of 393 non-industry interventional studies with no phase under Malnutrition, half reached primary completion within 21 months of starting (the median), counting those still running; a quarter within 10 and three quarters within 37. This study's planned 157 months is above that.
Counting every sponsor, half of 419 studies reached it within 22 months; a quarter within 11 and three quarters within 37.
How these figures are worked out, and which studies are left out of them.
This study is not yet recruiting, as verified in Dec 2025. You cannot join it, but the record below documents what was studied.
Get an email when the registry record changes — status, dates, results — or when someone posts here.
Sign in to followQuestions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.
Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.
Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.
Peking Union Medical College